Log in to search using one of your social media accounts:

 

Ipi Plus Nivo for Melanoma Patients With Brain Metastases Ipi Plus Nivo for Melanoma Patients With Brain Metastases
Two recent ASCO abstracts show important results, possibly practice-changing, on immunologic treatment in melanoma patients with brain metastases.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 20, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Sperm Banking Underutilized in Young Male Cancer Patients Sperm Banking Underutilized in Young Male Cancer Patients
Fertility preservation is an important aspect of cancer care, but young male cancer patients are underutilizing sperm banking.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 19, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

& quot;Massive & quot; Suffering: Pain Relief in Less Affluent Countries & quot;Massive & quot; Suffering: Pain Relief in Less Affluent Countries
In much of the world, patients suffering from serious illness and injury have little to no access to palliative care and adequate pain relief.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 18, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Price of Cancer Drugs Rises After Launch, Unfazed by Market Price of Cancer Drugs Rises After Launch, Unfazed by Market
The cost of oncology drugs, with few exceptions, continues to increase after they enter the market, and in the absence of any tangible reasons for the increase.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 13, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

First-Line Doxorubicin for Advanced Sarcoma, Not Combo? First-Line Doxorubicin for Advanced Sarcoma, Not Combo?
Doxorubicin should remain first-line therapy for patients with soft-tissue sarcoma, conclude trialists who compared it with a gemcitabine and docetaxel combination.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 27, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New Guidelines for Managing CAR T-Cell Acute Toxicities New Guidelines for Managing CAR T-Cell Acute Toxicities
Researchers at MD Anderson have developed a framework to help recognize and manage unique acute toxicities associated with CAR T-cell therapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 21, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Imatinib a Double-Edged Sword for Pregnant CML Patients Imatinib a Double-Edged Sword for Pregnant CML Patients
On the one hand, imatinib keeps the CML in check; on the other hand, it carries a risk for fetal congenital malformation if taken during pregnancy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 19, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Severe Health Problems Plague Survivors of Childhood CA Severe Health Problems Plague Survivors of Childhood CA
Specialized healthcare delivery is needed for diverse subgroups of adult cancer survivors with complex medical needs, say researchers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 18, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

R & D Investment Does Not Justify High Cost of Cancer Drugs R & D Investment Does Not Justify High Cost of Cancer Drugs
A new analysis found that the revenue from cancer drugs greatly exceeds the investment to develop them.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 11, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Lasker Awards Go to HPV Vaccine Researchers, Planned Parenthood Lasker Awards Go to HPV Vaccine Researchers, Planned Parenthood
A third award was for research on nutrient-activated TOR (target of rapamycin) proteins that regulate cell growth.News Alerts (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 6, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Expanding Germline Analyses to Prevent and Treat Cancers Expanding Germline Analyses to Prevent and Treat Cancers
An approach that used paired tumor-normal sequencing detected more inherited actionable gene mutations compared to clinical guideline-based testing.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 6, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Outreach Efforts to Improve CRC Screening Rates Fall Short Outreach Efforts to Improve CRC Screening Rates Fall Short
Efforts to improve screening for colorectal cancer (CRC), either with FIT testing or colonoscopy, did improve uptake but fell short of ideal targets.885204Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 5, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Jack West, MD: Top Five Lung Cancer Abstracts at ESMO 2017 Jack West, MD: Top Five Lung Cancer Abstracts at ESMO 2017
Lung cancer specialist Dr Jack West previews the most important lung cancer studies being presented at the ESMO 2017 Congress in Madrid.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 5, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Increase in CRC Deaths in Under-55s Confined to Whites Increase in CRC Deaths in Under-55s Confined to Whites
The increase in deaths from colorectal cancer (CRC) among younger adults (younger than 55 years) that has been recently highlighted is seen only among whites, not in blacks or other races.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 8, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Pembrolizumab, Larotrectinib Point to Future of Precision Medicine Pembrolizumab, Larotrectinib Point to Future of Precision Medicine
With the examples of pembrolizumab and larotrectinib, Dr Markman discusses how precision cancer medicine will likely change the landscape of cancer therapy.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 8, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

FDA OKs Nivolumab in Metastatic CRC Subtype FDA OKs Nivolumab in Metastatic CRC Subtype
The FDA has given accelerated approval to nivolumab for the treatment of microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 1, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

ASCO Adds MammaPrint to Breast Cancer Guideline ASCO Adds MammaPrint to Breast Cancer Guideline
In an update to its 2016 guideline, the American Society of Clinical Oncology (ASCO) recommends how to use the MammaPrint test to reduce adjuvant chemotherapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 11, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Clears Haegarda to Prevent Hereditary Angioedema Attacks FDA Clears Haegarda to Prevent Hereditary Angioedema Attacks
Haegarda is the first C1 esterase inhibitor (human) for at-home subcutaneous administration for the prevention of hereditary angioedema attacks in adolescents and adults.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 23, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Good IDEA: Drop Adjuvant Chemo From 6 to 3 Months in CRC Good IDEA: Drop Adjuvant Chemo From 6 to 3 Months in CRC
Dr John Marshall reports on the practice-changing results of the IDEA study in stage III colorectal cancer looking at duration of adjuvant chemotherapy, as presented at the ASCO plenary session.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 12, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

First Look at New CDK 4/6 Data in Metastatic Breast Cancer First Look at New CDK 4/6 Data in Metastatic Breast Cancer
ASCO 2017 featured a number of important studies looking at the role of CDK 4/6 inhibitors in patients with hormone receptor-positive, HER2-negative metastatic breast cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 5, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Prostate Cancer Diagnoses Fall as Use of PSA Test Declines Prostate Cancer Diagnoses Fall as Use of PSA Test Declines
Incidence rates of prostate cancer in the US are dropping, reflecting the declining use of the PSA test, but this leaves a huge amount undetected, warn experts.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 23, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

EPA Data Reveal Ties Between Environment, Cancer Rates EPA Data Reveal Ties Between Environment, Cancer Rates
New research using Environmental Protection Agency data shows that the overall environmental quality of a geographic location is associated with cancer incidence.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 9, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Untreated Breast Cancers Do Not Spontaneously Vanish Untreated Breast Cancers Do Not Spontaneously Vanish
Contrary to some suggestions that have been made in recent years, untreated breast cancers do not regress or disappear if left untreated.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 9, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Avelumab: Another Immunotherapy for Bladder Cancer Avelumab: Another Immunotherapy for Bladder Cancer
Avelumab has been approved in the US for second-line use in urothelial cancer, making it the fourth immunotherapy with this indication.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 9, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

G-CSF Use in Small Cell Lung Cancer: New Data'Comforting'G-CSF Use in Small Cell Lung Cancer: New Data'Comforting '
Although patients with SCLC given granulocyte colony-stimulating factors during chemo-radiotherapy had an increased risk for hematologic complications, the drugs can be used safely, say researchers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 9, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Questions Over'Flu Jab' in Lung Cancer Patients on PD Inhibitors Questions Over'Flu Jab' in Lung Cancer Patients on PD Inhibitors
Patients with cancer receiving immune checkpoint inhibitors could be at increased risk for adverse events compared with the general population if they are given a yearly flu jab, say Swiss researchers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 8, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

PD-Inhibitor Benefits'Continue Beyond Progression' in NSCLC PD-Inhibitor Benefits'Continue Beyond Progression' in NSCLC
Non-small cell lung cancer patients can benefit from immunotherapy even after progression, from both drug continuance and the ongoing effect of prior treatment on salvage therapy, reveal two studies.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 8, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

European Lung Cancer Conference (ELCC) 2017 European Lung Cancer Conference (ELCC) 2017
Read clinically focused news coverage of key developments from ELCC 2017.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 8, 2017 Category: Cancer & Oncology Tags: Conference Coverage Source Type: news

Do Women Need Lung Cancer Screening Less Often Than Men? Do Women Need Lung Cancer Screening Less Often Than Men?
Women could undergo low-dose computed tomography screening for lung cancer as little as once every 3 years vs annual screening in men, suggests a retrospective analysis of screening data.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 8, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

ASCO's Plan to Encourage Diversity in Oncology Workforce ASCO's Plan to Encourage Diversity in Oncology Workforce
ASCO's new strategic plan aims to close the diversity gap between oncologists, patients.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 5, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Survival Improves in mRCC With Surgical Metastasectomy Survival Improves in mRCC With Surgical Metastasectomy
Patients with metastatic renal cell carcinoma who had complete surgical metastasectomy have better survival outcomes than patients with no resection or incomplete resection of metastases.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 4, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New Biomarker Signals Poor Response in Prostate Cancer New Biomarker Signals Poor Response in Prostate Cancer
A new test identifies men with castration-resistant prostate cancer who have a poorer response to abiraterone and enzalutamide.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 4, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New Standard of Care for EGFR Mutation-Positive Advanced NSCLC New Standard of Care for EGFR Mutation-Positive Advanced NSCLC
Dr Jack West talks about the new role of osimertinib for NSCLC patients with EGFR mutation-positive acquired resistance.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 3, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Viewpoint Source Type: news

Found: Key Driver of Lung Cancer Evolution and Relapse Found: Key Driver of Lung Cancer Evolution and Relapse
The discovery of unstable chromosomes as the key driver in lung cancer also shows which patients relapse long before this can be seen with imaging.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 2, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Plain Packaging on Cigarette Packs May Cut Smoking Rates Plain Packaging on Cigarette Packs May Cut Smoking Rates
A ban on branded cigarette packets, similar to that introduced in Australia, could help reduce tobacco consumption by reducing the appeal of smoking, a systematic data review suggests.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 2, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Unique' DCIS Study: Double Mastectomy Not Needed'Unique' DCIS Study: Double Mastectomy Not Needed
Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 2, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Europe Approves Nivolumab for Head and Neck Cancer Europe Approves Nivolumab for Head and Neck Cancer
It's the first drug approved in this setting in Europe in more than a decade.International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 1, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

FDA Approves Durvalumab (Imfinzi) for Urothelial Cancer FDA Approves Durvalumab (Imfinzi) for Urothelial Cancer
It's an accelerated approval for patients with urothelial carcinoma, which is, most commonly, a type of bladder cancer.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 1, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

FDA Approves First New Drug for AML Since 1990 FDA Approves First New Drug for AML Since 1990
Midostaurin is indicated for the treatment of patients with newly diagnosed acute myeloid leukemia who have the FLT3 genetic mutation.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 28, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Breast Surgeon Found Guilty of'Wounding With Intent'Breast Surgeon Found Guilty of'Wounding With Intent '
After years of questions over his surgery on breast cancer patients, a criminal court has found Ian Paterson guilty of'wounding with intent. 'Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 28, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

First New Drug for Liver Cancer in a Decade: Regorafenib First New Drug for Liver Cancer in a Decade: Regorafenib
The FDA has approved an expanded indication for regorafenib to include hepatocellular carcinoma, making it the first drug to be approved for this cancer in a decade.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 28, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Dramatic Jump in Incidence of NETs Over Past 4 Decades Dramatic Jump in Incidence of NETs Over Past 4 Decades
The incidence of neuroendocrine tumors (NETs) has increased dramatically over the past 4 decades, but the rise may be due to improved diagnosis.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 27, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Renowned Neurosurgeon on Assisted Dying and His'Suicide Kit'Renowned Neurosurgeon on Assisted Dying and His'Suicide Kit '
Releasing a second memoir of his experiences resecting brain tumors, Henry Marsh, FRCS, also talks about assisted dying and his own suicide kit.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 27, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Troubles of the Billionaire'Moonshot' Doctor Troubles of the Billionaire'Moonshot' Doctor
Only months after being in the spotlight as a potential player in the Trump administration, a wealthy doctor is beset by a rash of controversiesMedscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 26, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

ASCO Issues Guideline on Castrate-Resistant Prostate Cancer ASCO Issues Guideline on Castrate-Resistant Prostate Cancer
The new document, a provisional clinical opinion, offers guidelines for treating chemotherapy-naive men who develop castrate-resistant prostate cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 25, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Takes Action Against'Bogus Cancer Cures'FDA Takes Action Against'Bogus Cancer Cures '
The FDA has sent warning letters to 14 companies that are'peddling bogus cancer cures'and are exploiting the cancer patients'desperation.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 25, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Many Men Have No Discussion of Pros and Cons Before PSA Test Many Men Have No Discussion of Pros and Cons Before PSA Test
A national survey shows that less than one third of men are discussing the pros and cons of prostate-specific antigen testing with their healthcare provider before undergoing screening.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 25, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Biosimilar Rutiximabs, and Inotuzumab, Coming to Europe Biosimilar Rutiximabs, and Inotuzumab, Coming to Europe
Two biosimilar rituximab products have been recommended for approval in Europe, as has inotuzumab ozogamicin for acute lymphoblastic leukemia.International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 24, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Possibility of'Cure' for Metastatic Prostate Cancer Possibility of'Cure' for Metastatic Prostate Cancer
A small study in 20 men with early-stage extrapelvic and bone metastases shows that aggressive multimodal therapy'can eliminate detectable disease. 'Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 21, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

ASTRO Releases First Guidelines for Oropharyngeal Cancer ASTRO Releases First Guidelines for Oropharyngeal Cancer
ASTRO releases its first guidelines for the management of oropharyngeal cancer but purposefully avoids distinguishing between HPV-positive and -negative disease despite differences in prognosis.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 20, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news